Cargando…

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study

OBJECTIVE: To compare the efficacy and safety of thrombolysis using Tenecteplase (TNK) versus alteplase in acute ischaemic stroke (AIS) patients within 4.5-hour window period. METHODS: This retrospective study involved the collection of data from consecutive AIS patients who underwent thrombolysis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhar, Nikita, Kumar, Mritunjai, Tiwari, Ashutosh, Desai, Ishita, Madhaw, Govind, Kumar, Niraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764915/ https://www.ncbi.nlm.nih.gov/pubmed/36561006 http://dx.doi.org/10.4103/aian.aian_1127_21

Ejemplares similares

Guillain-Barre Syndrome Associated with Scrub Typhus Infection: Uncommon or Under-Reported!
por: Kumar, Mritunjai, et al.
Publicado: (2022)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Non-COVID Neurological Emergencies: A Silent Killer Going Unnoticed during COVID-19 Pandemic
por: Dhar, Nikita, et al.
Publicado: (2021)

Comparison of Risk Factors, Clinico-Radiological Profile and Outcome in Patients with Acute, Subacute and Chronic Cerebral Venous Sinus Thrombosis
por: Desai, Ishita, et al.
Publicado: (2022)

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)

Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials
por: Liang, Huo, et al.
Publicado: (2023)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review
por: Potla, Neha, et al.
Publicado: (2022)

Is Tenecteplase a Viable Alternative to Alteplase in the Treatment of Acute Ischemic Stroke?
por: Vaishnav, Anand Girish
Publicado: (2022)

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

External Anal- and Urethral-Sphincter Electromyography for Differentiating MSA-P, PD and PSP: Using a Needle to Sort the Haystack!
por: Dhar, Nikita, et al.
Publicado: (2023)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Neurological manifestations of coronavirus disease 2019: exploring past to understand present
por: Desai, Ishita, et al.
Publicado: (2021)

Sleep Disorders in Patients with Parkinson's Disease during COVID-19 Pandemic: A Case–Control Study
por: Desai, Ishita, et al.
Publicado: (2022)

Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study
por: Mohan, Ayush, et al.
Publicado: (2023)

Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis
por: Meloni, Bruno P., et al.
Publicado: (2022)

Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China
por: Pan, Yuesong, et al.
Publicado: (2014)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
por: Alemseged, Fana, et al.
Publicado: (2021)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
por: Alper, Brian Scott, et al.
Publicado: (2020)

Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018)

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
por: Logallo, Nicola, et al.
Publicado: (2014)

Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital
por: Belkouch, Ahmed, et al.
Publicado: (2015)

Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
por: Owais, Mohammed, et al.
Publicado: (2018)

Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
por: Kate, Mahesh, et al.
Publicado: (2018)

Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
por: Kate, Mahesh, et al.
Publicado: (2018)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China
por: Zheng, Huaguang, et al.
Publicado: (2020)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
por: Kobeissi, Hassan, et al.
Publicado: (2023)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
por: Seners, Pierre, et al.
Publicado: (2019)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5–24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study
por: Wang, Lu, et al.
Publicado: (2023)

Erratum: Acute Ischemic Stroke Thrombolysis with Tenecteplase: An Institutional Experience from South India
Publicado: (2018)

Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety
por: Nepal, Gaurav, et al.
Publicado: (2018)

Real-world comparative safety and efficacy of tenecteplase versus alteplase in acute ischemic stroke patients with large vessel occlusion
por: Psychogios, Klearchos, et al.
Publicado: (2021)

Comparison of clinico-radiological profile, optical coherence tomography parameters, and outcome in MOGAD and Neuromyelitis optica spectrum disorder subtypes: A prospective observational study
por: Dhar, Nikita, et al.
Publicado: (2023)

Dietary and Environmental Risk Factors in Parkinson’s Disease and Alzheimer’s Disease: Beware of Your Food Plate and Your Surroundings!
por: Madhaw, Govind, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9au37er50d9ssla90v2ur4edc6